BCR and acute lymphoblastic leukemia: Our evaluation of the role of the PI3K pathway in leukemic cell growth and survival focused initially on BCR-ABL expressing leukemias, as PI3K signaling has been strongly implicated in malignant transformation and development of TKI-resistance in Ph+ ALL [3,6,14–16].